nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—peripheral nervous system neoplasm—malignant glioma	0.768	1	CtDrD
Alitretinoin—CYP1A2—Carmustine—malignant glioma	0.0309	1	CbGbCtD
Alitretinoin—CRABP2—pineal body—malignant glioma	0.00609	0.126	CbGeAlD
Alitretinoin—Behavior disorder—Temozolomide—malignant glioma	0.00434	0.0494	CcSEcCtD
Alitretinoin—Teratogenicity—Carmustine—malignant glioma	0.00247	0.0281	CcSEcCtD
Alitretinoin—CRABP1—embryo—malignant glioma	0.00229	0.0475	CbGeAlD
Alitretinoin—CRABP1—brainstem—malignant glioma	0.0021	0.0435	CbGeAlD
Alitretinoin—CRABP2—embryo—malignant glioma	0.00207	0.0429	CbGeAlD
Alitretinoin—CRABP1—retina—malignant glioma	0.00203	0.042	CbGeAlD
Alitretinoin—Brain oedema—Carmustine—malignant glioma	0.00181	0.0206	CcSEcCtD
Alitretinoin—Brain oedema—Temozolomide—malignant glioma	0.00175	0.0199	CcSEcCtD
Alitretinoin—RXRA—telencephalon—malignant glioma	0.00168	0.0348	CbGeAlD
Alitretinoin—Facial paralysis—Carmustine—malignant glioma	0.00163	0.0185	CcSEcCtD
Alitretinoin—Sensory disturbance—Temozolomide—malignant glioma	0.00161	0.0184	CcSEcCtD
Alitretinoin—Retinal haemorrhage—Carmustine—malignant glioma	0.00159	0.0181	CcSEcCtD
Alitretinoin—CRABP1—medulla oblongata—malignant glioma	0.00146	0.0303	CbGeAlD
Alitretinoin—Hemiplegia—Carmustine—malignant glioma	0.00145	0.0165	CcSEcCtD
Alitretinoin—Hemiplegia—Temozolomide—malignant glioma	0.0014	0.0159	CcSEcCtD
Alitretinoin—Clotting—Temozolomide—malignant glioma	0.0014	0.0159	CcSEcCtD
Alitretinoin—RXRB—telencephalon—malignant glioma	0.00139	0.0287	CbGeAlD
Alitretinoin—Abnormal behaviour—Temozolomide—malignant glioma	0.00134	0.0153	CcSEcCtD
Alitretinoin—CRABP1—midbrain—malignant glioma	0.00134	0.0277	CbGeAlD
Alitretinoin—RARG—retina—malignant glioma	0.00134	0.0277	CbGeAlD
Alitretinoin—CRABP2—medulla oblongata—malignant glioma	0.00132	0.0274	CbGeAlD
Alitretinoin—CRABP1—spinal cord—malignant glioma	0.00131	0.0271	CbGeAlD
Alitretinoin—VIIth nerve paralysis—Carmustine—malignant glioma	0.00126	0.0144	CcSEcCtD
Alitretinoin—Intracranial pressure increased—Carmustine—malignant glioma	0.00124	0.0141	CcSEcCtD
Alitretinoin—Impaired healing—Carmustine—malignant glioma	0.0012	0.0136	CcSEcCtD
Alitretinoin—CRABP2—spinal cord—malignant glioma	0.00118	0.0245	CbGeAlD
Alitretinoin—RXRG—medulla oblongata—malignant glioma	0.00116	0.024	CbGeAlD
Alitretinoin—RARA—telencephalon—malignant glioma	0.00116	0.024	CbGeAlD
Alitretinoin—Lung infiltration—Carmustine—malignant glioma	0.0011	0.0126	CcSEcCtD
Alitretinoin—CRABP1—central nervous system—malignant glioma	0.00106	0.0219	CbGeAlD
Alitretinoin—RXRG—midbrain—malignant glioma	0.00106	0.0219	CbGeAlD
Alitretinoin—Disorder sight—Temozolomide—malignant glioma	0.00105	0.012	CcSEcCtD
Alitretinoin—CRABP1—cerebellum—malignant glioma	0.00104	0.0215	CbGeAlD
Alitretinoin—Tretinoin—CYP2C18—malignant glioma	0.00103	0.574	CrCbGaD
Alitretinoin—RXRG—spinal cord—malignant glioma	0.00103	0.0214	CbGeAlD
Alitretinoin—CRABP2—central nervous system—malignant glioma	0.000958	0.0198	CbGeAlD
Alitretinoin—RXRA—central nervous system—malignant glioma	0.000954	0.0198	CbGeAlD
Alitretinoin—CRABP2—cerebellum—malignant glioma	0.000936	0.0194	CbGeAlD
Alitretinoin—Cerebral haemorrhage—Carmustine—malignant glioma	0.000936	0.0106	CcSEcCtD
Alitretinoin—Cerebral haemorrhage—Temozolomide—malignant glioma	0.000904	0.0103	CcSEcCtD
Alitretinoin—Skin hyperpigmentation—Carmustine—malignant glioma	0.000871	0.0099	CcSEcCtD
Alitretinoin—Febrile neutropenia—Carmustine—malignant glioma	0.000861	0.00979	CcSEcCtD
Alitretinoin—Visual acuity reduced—Temozolomide—malignant glioma	0.000842	0.00957	CcSEcCtD
Alitretinoin—CRABP1—brain—malignant glioma	0.000841	0.0174	CbGeAlD
Alitretinoin—RARB—cerebellum—malignant glioma	0.000837	0.0173	CbGeAlD
Alitretinoin—RXRG—central nervous system—malignant glioma	0.000837	0.0173	CbGeAlD
Alitretinoin—Febrile neutropenia—Temozolomide—malignant glioma	0.000832	0.00946	CcSEcCtD
Alitretinoin—Encephalopathy—Carmustine—malignant glioma	0.000807	0.00917	CcSEcCtD
Alitretinoin—Aphasia—Carmustine—malignant glioma	0.000799	0.00908	CcSEcCtD
Alitretinoin—RXRB—central nervous system—malignant glioma	0.000787	0.0163	CbGeAlD
Alitretinoin—Embolism—Temozolomide—malignant glioma	0.00078	0.00886	CcSEcCtD
Alitretinoin—Aphasia—Temozolomide—malignant glioma	0.000772	0.00877	CcSEcCtD
Alitretinoin—RXRB—cerebellum—malignant glioma	0.00077	0.0159	CbGeAlD
Alitretinoin—Tretinoin—CYP2B6—malignant glioma	0.000768	0.426	CrCbGaD
Alitretinoin—CRABP2—brain—malignant glioma	0.000761	0.0158	CbGeAlD
Alitretinoin—RXRA—brain—malignant glioma	0.000757	0.0157	CbGeAlD
Alitretinoin—Thrombosis—Carmustine—malignant glioma	0.000732	0.00832	CcSEcCtD
Alitretinoin—Lung disorder—Temozolomide—malignant glioma	0.000707	0.00804	CcSEcCtD
Alitretinoin—RARG—central nervous system—malignant glioma	0.000699	0.0145	CbGeAlD
Alitretinoin—RARG—cerebellum—malignant glioma	0.000683	0.0142	CbGeAlD
Alitretinoin—Scotoma—Carmustine—malignant glioma	0.000682	0.00775	CcSEcCtD
Alitretinoin—RARB—brain—malignant glioma	0.00068	0.0141	CbGeAlD
Alitretinoin—Hepatotoxicity—Carmustine—malignant glioma	0.000671	0.00762	CcSEcCtD
Alitretinoin—RXRG—brain—malignant glioma	0.000665	0.0138	CbGeAlD
Alitretinoin—Scotoma—Temozolomide—malignant glioma	0.000659	0.00749	CcSEcCtD
Alitretinoin—RARA—central nervous system—malignant glioma	0.000657	0.0136	CbGeAlD
Alitretinoin—Hepatotoxicity—Temozolomide—malignant glioma	0.000648	0.00737	CcSEcCtD
Alitretinoin—Coagulopathy—Temozolomide—malignant glioma	0.000643	0.00731	CcSEcCtD
Alitretinoin—RARA—cerebellum—malignant glioma	0.000642	0.0133	CbGeAlD
Alitretinoin—Hyperaesthesia—Temozolomide—malignant glioma	0.000638	0.00725	CcSEcCtD
Alitretinoin—Memory impairment—Temozolomide—malignant glioma	0.000638	0.00725	CcSEcCtD
Alitretinoin—RXRB—brain—malignant glioma	0.000625	0.0129	CbGeAlD
Alitretinoin—Drug interaction—Carmustine—malignant glioma	0.000558	0.00635	CcSEcCtD
Alitretinoin—RARG—brain—malignant glioma	0.000555	0.0115	CbGeAlD
Alitretinoin—Leukocytosis—Carmustine—malignant glioma	0.000551	0.00626	CcSEcCtD
Alitretinoin—Herpes simplex—Temozolomide—malignant glioma	0.000543	0.00617	CcSEcCtD
Alitretinoin—Gait disturbance—Carmustine—malignant glioma	0.000531	0.00603	CcSEcCtD
Alitretinoin—Hearing impaired—Temozolomide—malignant glioma	0.000526	0.00598	CcSEcCtD
Alitretinoin—Neck pain—Carmustine—malignant glioma	0.000524	0.00596	CcSEcCtD
Alitretinoin—RARA—brain—malignant glioma	0.000522	0.0108	CbGeAlD
Alitretinoin—Injection site reaction—Carmustine—malignant glioma	0.000515	0.00585	CcSEcCtD
Alitretinoin—Gait disturbance—Temozolomide—malignant glioma	0.000513	0.00583	CcSEcCtD
Alitretinoin—Respiratory failure—Temozolomide—malignant glioma	0.00051	0.00579	CcSEcCtD
Alitretinoin—Musculoskeletal pain—Temozolomide—malignant glioma	0.000507	0.00576	CcSEcCtD
Alitretinoin—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.000501	0.00569	CcSEcCtD
Alitretinoin—Depressed level of consciousness—Carmustine—malignant glioma	0.0005	0.00569	CcSEcCtD
Alitretinoin—Candida infection—Carmustine—malignant glioma	0.000495	0.00562	CcSEcCtD
Alitretinoin—Skin exfoliation—Carmustine—malignant glioma	0.000495	0.00562	CcSEcCtD
Alitretinoin—Depressed level of consciousness—Temozolomide—malignant glioma	0.000483	0.00549	CcSEcCtD
Alitretinoin—Skin exfoliation—Temozolomide—malignant glioma	0.000478	0.00543	CcSEcCtD
Alitretinoin—Candida infection—Temozolomide—malignant glioma	0.000478	0.00543	CcSEcCtD
Alitretinoin—Coma—Carmustine—malignant glioma	0.000473	0.00538	CcSEcCtD
Alitretinoin—Dry eye—Temozolomide—malignant glioma	0.000462	0.00526	CcSEcCtD
Alitretinoin—ABCB1—blood vessel—malignant glioma	0.000453	0.00938	CbGeAlD
Alitretinoin—Sepsis—Carmustine—malignant glioma	0.00045	0.00511	CcSEcCtD
Alitretinoin—Phlebitis—Carmustine—malignant glioma	0.000436	0.00496	CcSEcCtD
Alitretinoin—Diabetes mellitus—Carmustine—malignant glioma	0.000432	0.00491	CcSEcCtD
Alitretinoin—Swelling—Carmustine—malignant glioma	0.000426	0.00484	CcSEcCtD
Alitretinoin—Ear pain—Temozolomide—malignant glioma	0.000426	0.00484	CcSEcCtD
Alitretinoin—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.000418	0.00475	CcSEcCtD
Alitretinoin—Deafness—Temozolomide—malignant glioma	0.000406	0.00462	CcSEcCtD
Alitretinoin—Nasal congestion—Temozolomide—malignant glioma	0.000399	0.00453	CcSEcCtD
Alitretinoin—Dermatitis exfoliative—Temozolomide—malignant glioma	0.000385	0.00438	CcSEcCtD
Alitretinoin—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.000376	0.00427	CcSEcCtD
Alitretinoin—Face oedema—Carmustine—malignant glioma	0.000363	0.00413	CcSEcCtD
Alitretinoin—Affect lability—Temozolomide—malignant glioma	0.000358	0.00407	CcSEcCtD
Alitretinoin—Face oedema—Temozolomide—malignant glioma	0.000351	0.00399	CcSEcCtD
Alitretinoin—Mood swings—Temozolomide—malignant glioma	0.000344	0.00391	CcSEcCtD
Alitretinoin—Dehydration—Temozolomide—malignant glioma	0.000338	0.00384	CcSEcCtD
Alitretinoin—Dry skin—Temozolomide—malignant glioma	0.000333	0.00379	CcSEcCtD
Alitretinoin—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.000327	0.00372	CcSEcCtD
Alitretinoin—Dysphagia—Carmustine—malignant glioma	0.000325	0.00369	CcSEcCtD
Alitretinoin—Abdominal distension—Temozolomide—malignant glioma	0.000316	0.00359	CcSEcCtD
Alitretinoin—Dysphagia—Temozolomide—malignant glioma	0.000314	0.00357	CcSEcCtD
Alitretinoin—Sweating increased—Temozolomide—malignant glioma	0.000306	0.00348	CcSEcCtD
Alitretinoin—Neutropenia—Carmustine—malignant glioma	0.000304	0.00345	CcSEcCtD
Alitretinoin—Neutropenia—Temozolomide—malignant glioma	0.000294	0.00334	CcSEcCtD
Alitretinoin—Dysuria—Temozolomide—malignant glioma	0.000294	0.00334	CcSEcCtD
Alitretinoin—Upper respiratory tract infection—Temozolomide—malignant glioma	0.000292	0.00332	CcSEcCtD
Alitretinoin—Pneumonia—Carmustine—malignant glioma	0.000291	0.00331	CcSEcCtD
Alitretinoin—Pollakiuria—Temozolomide—malignant glioma	0.00029	0.0033	CcSEcCtD
Alitretinoin—Depression—Carmustine—malignant glioma	0.000289	0.00328	CcSEcCtD
Alitretinoin—Photosensitivity reaction—Temozolomide—malignant glioma	0.000287	0.00326	CcSEcCtD
Alitretinoin—Weight increased—Temozolomide—malignant glioma	0.000286	0.00325	CcSEcCtD
Alitretinoin—Renal failure—Carmustine—malignant glioma	0.000285	0.00324	CcSEcCtD
Alitretinoin—Weight decreased—Temozolomide—malignant glioma	0.000284	0.00323	CcSEcCtD
Alitretinoin—Neuropathy peripheral—Carmustine—malignant glioma	0.000284	0.00323	CcSEcCtD
Alitretinoin—Stomatitis—Carmustine—malignant glioma	0.000282	0.00321	CcSEcCtD
Alitretinoin—Urinary tract infection—Carmustine—malignant glioma	0.000282	0.0032	CcSEcCtD
Alitretinoin—Pneumonia—Temozolomide—malignant glioma	0.000282	0.0032	CcSEcCtD
Alitretinoin—Infestation—Temozolomide—malignant glioma	0.00028	0.00318	CcSEcCtD
Alitretinoin—Infestation NOS—Temozolomide—malignant glioma	0.00028	0.00318	CcSEcCtD
Alitretinoin—Depression—Temozolomide—malignant glioma	0.000279	0.00317	CcSEcCtD
Alitretinoin—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000278	0.00316	CcSEcCtD
Alitretinoin—Neuropathy peripheral—Temozolomide—malignant glioma	0.000275	0.00312	CcSEcCtD
Alitretinoin—Stomatitis—Temozolomide—malignant glioma	0.000273	0.0031	CcSEcCtD
Alitretinoin—Urinary tract infection—Temozolomide—malignant glioma	0.000272	0.00309	CcSEcCtD
Alitretinoin—ABCB1—embryo—malignant glioma	0.00027	0.00559	CbGeAlD
Alitretinoin—Sinusitis—Temozolomide—malignant glioma	0.000263	0.00299	CcSEcCtD
Alitretinoin—Haemoglobin—Carmustine—malignant glioma	0.000261	0.00297	CcSEcCtD
Alitretinoin—Haemorrhage—Carmustine—malignant glioma	0.00026	0.00296	CcSEcCtD
Alitretinoin—Hallucination—Carmustine—malignant glioma	0.000259	0.00294	CcSEcCtD
Alitretinoin—Hypoaesthesia—Carmustine—malignant glioma	0.000259	0.00294	CcSEcCtD
Alitretinoin—Oedema peripheral—Carmustine—malignant glioma	0.000256	0.00291	CcSEcCtD
Alitretinoin—Haemoglobin—Temozolomide—malignant glioma	0.000253	0.00287	CcSEcCtD
Alitretinoin—Hepatitis—Temozolomide—malignant glioma	0.000251	0.00286	CcSEcCtD
Alitretinoin—Haemorrhage—Temozolomide—malignant glioma	0.000251	0.00286	CcSEcCtD
Alitretinoin—Visual impairment—Carmustine—malignant glioma	0.000251	0.00285	CcSEcCtD
Alitretinoin—Hypoaesthesia—Temozolomide—malignant glioma	0.00025	0.00284	CcSEcCtD
Alitretinoin—Hallucination—Temozolomide—malignant glioma	0.00025	0.00284	CcSEcCtD
Alitretinoin—Pharyngitis—Temozolomide—malignant glioma	0.00025	0.00284	CcSEcCtD
Alitretinoin—Urinary tract disorder—Temozolomide—malignant glioma	0.000248	0.00282	CcSEcCtD
Alitretinoin—Oedema peripheral—Temozolomide—malignant glioma	0.000248	0.00281	CcSEcCtD
Alitretinoin—Urethral disorder—Temozolomide—malignant glioma	0.000246	0.0028	CcSEcCtD
Alitretinoin—Eye disorder—Carmustine—malignant glioma	0.000243	0.00276	CcSEcCtD
Alitretinoin—Visual impairment—Temozolomide—malignant glioma	0.000242	0.00275	CcSEcCtD
Alitretinoin—Flushing—Carmustine—malignant glioma	0.000241	0.00274	CcSEcCtD
Alitretinoin—ABCB1—retina—malignant glioma	0.000239	0.00495	CbGeAlD
Alitretinoin—Erythema multiforme—Temozolomide—malignant glioma	0.000238	0.0027	CcSEcCtD
Alitretinoin—Eye disorder—Temozolomide—malignant glioma	0.000235	0.00267	CcSEcCtD
Alitretinoin—Tinnitus—Temozolomide—malignant glioma	0.000234	0.00266	CcSEcCtD
Alitretinoin—Flushing—Temozolomide—malignant glioma	0.000233	0.00265	CcSEcCtD
Alitretinoin—Arrhythmia—Carmustine—malignant glioma	0.000232	0.00264	CcSEcCtD
Alitretinoin—Alopecia—Carmustine—malignant glioma	0.00023	0.00261	CcSEcCtD
Alitretinoin—Angiopathy—Temozolomide—malignant glioma	0.000228	0.00259	CcSEcCtD
Alitretinoin—Mental disorder—Carmustine—malignant glioma	0.000228	0.00259	CcSEcCtD
Alitretinoin—Erythema—Carmustine—malignant glioma	0.000226	0.00257	CcSEcCtD
Alitretinoin—Malnutrition—Carmustine—malignant glioma	0.000226	0.00257	CcSEcCtD
Alitretinoin—Chills—Temozolomide—malignant glioma	0.000226	0.00256	CcSEcCtD
Alitretinoin—Alopecia—Temozolomide—malignant glioma	0.000222	0.00252	CcSEcCtD
Alitretinoin—Mental disorder—Temozolomide—malignant glioma	0.00022	0.0025	CcSEcCtD
Alitretinoin—ABCB1—telencephalon—malignant glioma	0.00022	0.00455	CbGeAlD
Alitretinoin—Back pain—Carmustine—malignant glioma	0.000219	0.00249	CcSEcCtD
Alitretinoin—Malnutrition—Temozolomide—malignant glioma	0.000219	0.00249	CcSEcCtD
Alitretinoin—Erythema—Temozolomide—malignant glioma	0.000219	0.00249	CcSEcCtD
Alitretinoin—Vision blurred—Carmustine—malignant glioma	0.000213	0.00243	CcSEcCtD
Alitretinoin—Tremor—Carmustine—malignant glioma	0.000212	0.00241	CcSEcCtD
Alitretinoin—Back pain—Temozolomide—malignant glioma	0.000212	0.00241	CcSEcCtD
Alitretinoin—Anaemia—Carmustine—malignant glioma	0.000209	0.00238	CcSEcCtD
Alitretinoin—Agitation—Carmustine—malignant glioma	0.000208	0.00237	CcSEcCtD
Alitretinoin—Vision blurred—Temozolomide—malignant glioma	0.000206	0.00234	CcSEcCtD
Alitretinoin—Tremor—Temozolomide—malignant glioma	0.000205	0.00233	CcSEcCtD
Alitretinoin—Ill-defined disorder—Temozolomide—malignant glioma	0.000203	0.00231	CcSEcCtD
Alitretinoin—Anaemia—Temozolomide—malignant glioma	0.000202	0.0023	CcSEcCtD
Alitretinoin—Agitation—Temozolomide—malignant glioma	0.000201	0.00229	CcSEcCtD
Alitretinoin—Malaise—Temozolomide—malignant glioma	0.000197	0.00224	CcSEcCtD
Alitretinoin—Convulsion—Carmustine—malignant glioma	0.000196	0.00223	CcSEcCtD
Alitretinoin—Hypertension—Carmustine—malignant glioma	0.000196	0.00222	CcSEcCtD
Alitretinoin—Palpitations—Temozolomide—malignant glioma	0.000193	0.0022	CcSEcCtD
Alitretinoin—Chest pain—Carmustine—malignant glioma	0.000193	0.00219	CcSEcCtD
Alitretinoin—Myalgia—Carmustine—malignant glioma	0.000193	0.00219	CcSEcCtD
Alitretinoin—Anxiety—Carmustine—malignant glioma	0.000192	0.00218	CcSEcCtD
Alitretinoin—Cough—Temozolomide—malignant glioma	0.000191	0.00217	CcSEcCtD
Alitretinoin—Convulsion—Temozolomide—malignant glioma	0.00019	0.00216	CcSEcCtD
Alitretinoin—Hypertension—Temozolomide—malignant glioma	0.000189	0.00215	CcSEcCtD
Alitretinoin—Confusional state—Carmustine—malignant glioma	0.000186	0.00212	CcSEcCtD
Alitretinoin—Arthralgia—Temozolomide—malignant glioma	0.000186	0.00212	CcSEcCtD
Alitretinoin—Myalgia—Temozolomide—malignant glioma	0.000186	0.00212	CcSEcCtD
Alitretinoin—Anxiety—Temozolomide—malignant glioma	0.000186	0.00211	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000185	0.0021	CcSEcCtD
Alitretinoin—Oedema—Carmustine—malignant glioma	0.000185	0.0021	CcSEcCtD
Alitretinoin—Discomfort—Temozolomide—malignant glioma	0.000184	0.00209	CcSEcCtD
Alitretinoin—Infection—Carmustine—malignant glioma	0.000184	0.00209	CcSEcCtD
Alitretinoin—Dry mouth—Temozolomide—malignant glioma	0.000182	0.00207	CcSEcCtD
Alitretinoin—Thrombocytopenia—Carmustine—malignant glioma	0.000181	0.00206	CcSEcCtD
Alitretinoin—Tachycardia—Carmustine—malignant glioma	0.00018	0.00205	CcSEcCtD
Alitretinoin—Confusional state—Temozolomide—malignant glioma	0.00018	0.00205	CcSEcCtD
Alitretinoin—Anaphylactic shock—Temozolomide—malignant glioma	0.000179	0.00203	CcSEcCtD
Alitretinoin—Oedema—Temozolomide—malignant glioma	0.000179	0.00203	CcSEcCtD
Alitretinoin—Infection—Temozolomide—malignant glioma	0.000177	0.00202	CcSEcCtD
Alitretinoin—Anorexia—Carmustine—malignant glioma	0.000176	0.002	CcSEcCtD
Alitretinoin—Nervous system disorder—Temozolomide—malignant glioma	0.000175	0.00199	CcSEcCtD
Alitretinoin—Thrombocytopenia—Temozolomide—malignant glioma	0.000175	0.00199	CcSEcCtD
Alitretinoin—Skin disorder—Temozolomide—malignant glioma	0.000173	0.00197	CcSEcCtD
Alitretinoin—Hypotension—Carmustine—malignant glioma	0.000173	0.00196	CcSEcCtD
Alitretinoin—Hyperhidrosis—Temozolomide—malignant glioma	0.000173	0.00196	CcSEcCtD
Alitretinoin—ABCB1—medulla oblongata—malignant glioma	0.000173	0.00357	CbGeAlD
Alitretinoin—Anorexia—Temozolomide—malignant glioma	0.00017	0.00193	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000168	0.00191	CcSEcCtD
Alitretinoin—Insomnia—Carmustine—malignant glioma	0.000167	0.0019	CcSEcCtD
Alitretinoin—Paraesthesia—Carmustine—malignant glioma	0.000166	0.00189	CcSEcCtD
Alitretinoin—Dyspnoea—Carmustine—malignant glioma	0.000165	0.00187	CcSEcCtD
Alitretinoin—Somnolence—Carmustine—malignant glioma	0.000164	0.00187	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000163	0.00185	CcSEcCtD
Alitretinoin—Insomnia—Temozolomide—malignant glioma	0.000162	0.00184	CcSEcCtD
Alitretinoin—Decreased appetite—Carmustine—malignant glioma	0.000161	0.00183	CcSEcCtD
Alitretinoin—Paraesthesia—Temozolomide—malignant glioma	0.00016	0.00182	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Carmustine—malignant glioma	0.00016	0.00181	CcSEcCtD
Alitretinoin—Dyspnoea—Temozolomide—malignant glioma	0.000159	0.00181	CcSEcCtD
Alitretinoin—Somnolence—Temozolomide—malignant glioma	0.000159	0.0018	CcSEcCtD
Alitretinoin—Pain—Carmustine—malignant glioma	0.000158	0.0018	CcSEcCtD
Alitretinoin—Constipation—Carmustine—malignant glioma	0.000158	0.0018	CcSEcCtD
Alitretinoin—ABCB1—midbrain—malignant glioma	0.000158	0.00327	CbGeAlD
Alitretinoin—Dyspepsia—Temozolomide—malignant glioma	0.000157	0.00179	CcSEcCtD
Alitretinoin—Decreased appetite—Temozolomide—malignant glioma	0.000155	0.00176	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000154	0.00175	CcSEcCtD
Alitretinoin—Fatigue—Temozolomide—malignant glioma	0.000154	0.00175	CcSEcCtD
Alitretinoin—ABCB1—spinal cord—malignant glioma	0.000154	0.00319	CbGeAlD
Alitretinoin—Pain—Temozolomide—malignant glioma	0.000153	0.00174	CcSEcCtD
Alitretinoin—Constipation—Temozolomide—malignant glioma	0.000153	0.00174	CcSEcCtD
Alitretinoin—Feeling abnormal—Carmustine—malignant glioma	0.000152	0.00173	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Carmustine—malignant glioma	0.000151	0.00172	CcSEcCtD
Alitretinoin—Feeling abnormal—Temozolomide—malignant glioma	0.000147	0.00167	CcSEcCtD
Alitretinoin—Abdominal pain—Carmustine—malignant glioma	0.000146	0.00166	CcSEcCtD
Alitretinoin—Body temperature increased—Carmustine—malignant glioma	0.000146	0.00166	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Temozolomide—malignant glioma	0.000146	0.00166	CcSEcCtD
Alitretinoin—Urticaria—Temozolomide—malignant glioma	0.000142	0.00161	CcSEcCtD
Alitretinoin—Abdominal pain—Temozolomide—malignant glioma	0.000141	0.0016	CcSEcCtD
Alitretinoin—Body temperature increased—Temozolomide—malignant glioma	0.000141	0.0016	CcSEcCtD
Alitretinoin—Hypersensitivity—Carmustine—malignant glioma	0.000136	0.00155	CcSEcCtD
Alitretinoin—Asthenia—Carmustine—malignant glioma	0.000133	0.00151	CcSEcCtD
Alitretinoin—Hypersensitivity—Temozolomide—malignant glioma	0.000132	0.0015	CcSEcCtD
Alitretinoin—Asthenia—Temozolomide—malignant glioma	0.000128	0.00146	CcSEcCtD
Alitretinoin—Diarrhoea—Carmustine—malignant glioma	0.000126	0.00144	CcSEcCtD
Alitretinoin—Pruritus—Temozolomide—malignant glioma	0.000126	0.00144	CcSEcCtD
Alitretinoin—ABCB1—central nervous system—malignant glioma	0.000125	0.00259	CbGeAlD
Alitretinoin—Dizziness—Carmustine—malignant glioma	0.000122	0.00139	CcSEcCtD
Alitretinoin—Diarrhoea—Temozolomide—malignant glioma	0.000122	0.00139	CcSEcCtD
Alitretinoin—ABCB1—cerebellum—malignant glioma	0.000122	0.00253	CbGeAlD
Alitretinoin—Dizziness—Temozolomide—malignant glioma	0.000118	0.00134	CcSEcCtD
Alitretinoin—Vomiting—Carmustine—malignant glioma	0.000118	0.00134	CcSEcCtD
Alitretinoin—Rash—Carmustine—malignant glioma	0.000117	0.00132	CcSEcCtD
Alitretinoin—Dermatitis—Carmustine—malignant glioma	0.000116	0.00132	CcSEcCtD
Alitretinoin—Headache—Carmustine—malignant glioma	0.000116	0.00132	CcSEcCtD
Alitretinoin—Vomiting—Temozolomide—malignant glioma	0.000114	0.00129	CcSEcCtD
Alitretinoin—Rash—Temozolomide—malignant glioma	0.000113	0.00128	CcSEcCtD
Alitretinoin—Dermatitis—Temozolomide—malignant glioma	0.000113	0.00128	CcSEcCtD
Alitretinoin—Headache—Temozolomide—malignant glioma	0.000112	0.00127	CcSEcCtD
Alitretinoin—Nausea—Carmustine—malignant glioma	0.00011	0.00125	CcSEcCtD
Alitretinoin—Nausea—Temozolomide—malignant glioma	0.000106	0.00121	CcSEcCtD
Alitretinoin—ABCB1—brain—malignant glioma	9.91e-05	0.00205	CbGeAlD
Alitretinoin—RARG—Gene Expression—NCOR1—malignant glioma	3.37e-05	0.000534	CbGpPWpGaD
Alitretinoin—CYP1A2—Arachidonic acid metabolism—PTGS2—malignant glioma	3.32e-05	0.000526	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—CDKN2B—malignant glioma	3.31e-05	0.000524	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	3.31e-05	0.000524	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—malignant glioma	3.3e-05	0.000523	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—malignant glioma	3.29e-05	0.000521	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—TNF—malignant glioma	3.27e-05	0.000519	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—CDKN2B—malignant glioma	3.25e-05	0.000515	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—SLC6A3—malignant glioma	3.23e-05	0.000511	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—PTGS1—malignant glioma	3.23e-05	0.000511	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—CDKN2B—malignant glioma	3.19e-05	0.000505	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—CAV1—malignant glioma	3.17e-05	0.000502	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—CAV1—malignant glioma	3.17e-05	0.000502	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—NCOR1—malignant glioma	3.14e-05	0.000497	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	3.11e-05	0.000492	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—NCOR1—malignant glioma	3.09e-05	0.000489	CbGpPWpGaD
Alitretinoin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—malignant glioma	3.07e-05	0.000486	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—CDKN2B—malignant glioma	3.06e-05	0.000485	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—CDKN2B—malignant glioma	3.06e-05	0.000485	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—PTK2—malignant glioma	3.03e-05	0.000479	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—NCOR1—malignant glioma	3.03e-05	0.000479	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.02e-05	0.000479	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.02e-05	0.000479	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—RTEL1—malignant glioma	3.02e-05	0.000479	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IFNG—malignant glioma	3.01e-05	0.000477	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—HES1—malignant glioma	2.97e-05	0.000471	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	2.96e-05	0.000469	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—NCOR1—malignant glioma	2.96e-05	0.000468	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—DNMT3B—malignant glioma	2.93e-05	0.000465	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—NCOR1—malignant glioma	2.9e-05	0.00046	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—NCOR1—malignant glioma	2.9e-05	0.00046	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	2.89e-05	0.000458	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PIK3CG—malignant glioma	2.88e-05	0.000457	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PIK3CG—malignant glioma	2.88e-05	0.000457	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—APOD—malignant glioma	2.88e-05	0.000457	CbGpPWpGaD
Alitretinoin—RARG—Generic Transcription Pathway—MYC—malignant glioma	2.86e-05	0.000454	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—HIST1H3B—malignant glioma	2.85e-05	0.000452	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	2.81e-05	0.000445	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—IDH2—malignant glioma	2.8e-05	0.000443	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—CXCL8—malignant glioma	2.8e-05	0.000443	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	2.8e-05	0.000443	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PPARG—malignant glioma	2.78e-05	0.000441	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PPARG—malignant glioma	2.78e-05	0.000441	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	2.69e-05	0.000426	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL1B—malignant glioma	2.69e-05	0.000425	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—CASP3—malignant glioma	2.68e-05	0.000424	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL2—malignant glioma	2.68e-05	0.000424	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	2.66e-05	0.000422	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.64e-05	0.000418	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CYP2B6—malignant glioma	2.63e-05	0.000417	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—malignant glioma	2.63e-05	0.000416	CbGpPWpGaD
Alitretinoin—RXRG—Generic Transcription Pathway—MYC—malignant glioma	2.62e-05	0.000415	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	2.58e-05	0.000409	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	2.57e-05	0.000408	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—MYC—malignant glioma	2.57e-05	0.000407	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—NOTCH1—malignant glioma	2.56e-05	0.000406	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PIK3CD—malignant glioma	2.54e-05	0.000402	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PIK3CD—malignant glioma	2.54e-05	0.000402	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—FGFR1—malignant glioma	2.53e-05	0.000401	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	2.53e-05	0.0004	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	2.52e-05	0.000399	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	2.52e-05	0.000399	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—MYC—malignant glioma	2.46e-05	0.00039	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—MYC—malignant glioma	2.46e-05	0.00039	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	2.42e-05	0.000383	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—PPARG—malignant glioma	2.42e-05	0.000383	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—RTEL1—malignant glioma	2.41e-05	0.000382	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—IDH1—malignant glioma	2.41e-05	0.000381	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	2.41e-05	0.000381	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	2.4e-05	0.00038	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	2.4e-05	0.00038	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	2.39e-05	0.000378	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—GSTP1—malignant glioma	2.39e-05	0.000378	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—NOTCH1—malignant glioma	2.38e-05	0.000378	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—KDR—malignant glioma	2.38e-05	0.000377	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	2.38e-05	0.000377	CbGpPWpGaD
Alitretinoin—CYP1A2—Metapathway biotransformation—GSTP1—malignant glioma	2.35e-05	0.000373	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—NOTCH1—malignant glioma	2.34e-05	0.000371	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MET—malignant glioma	2.33e-05	0.000369	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—SPHK1—malignant glioma	2.33e-05	0.000369	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—NOTCH1—malignant glioma	2.3e-05	0.000364	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CYP2C18—malignant glioma	2.28e-05	0.000362	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—VEGFA—malignant glioma	2.27e-05	0.00036	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—PPARG—malignant glioma	2.25e-05	0.000357	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—NOTCH1—malignant glioma	2.24e-05	0.000356	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—PPARG—malignant glioma	2.21e-05	0.00035	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PIK3CB—malignant glioma	2.21e-05	0.00035	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PIK3CB—malignant glioma	2.21e-05	0.00035	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—NOTCH1—malignant glioma	2.2e-05	0.000349	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—NOTCH1—malignant glioma	2.2e-05	0.000349	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—H3F3A—malignant glioma	2.2e-05	0.000349	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	2.19e-05	0.000347	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PTGS2—malignant glioma	2.19e-05	0.000347	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PTGS2—malignant glioma	2.19e-05	0.000347	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—PPARG—malignant glioma	2.17e-05	0.000344	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	2.16e-05	0.000342	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—PTPN11—malignant glioma	2.16e-05	0.000342	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.15e-05	0.000341	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	2.12e-05	0.000336	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—PPARG—malignant glioma	2.12e-05	0.000336	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—PPARG—malignant glioma	2.08e-05	0.000329	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—PPARG—malignant glioma	2.08e-05	0.000329	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—NOTCH3—malignant glioma	2.07e-05	0.000328	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—AKT2—malignant glioma	2.01e-05	0.000318	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.96e-05	0.000311	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—TNF—malignant glioma	1.95e-05	0.000309	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MMP2—malignant glioma	1.94e-05	0.000308	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	1.94e-05	0.000307	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PTEN—malignant glioma	1.91e-05	0.000302	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PTEN—malignant glioma	1.91e-05	0.000302	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.89e-05	0.0003	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	1.88e-05	0.000297	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—NOTCH2—malignant glioma	1.85e-05	0.000294	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	1.85e-05	0.000294	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—FGF2—malignant glioma	1.85e-05	0.000293	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GSTT1—malignant glioma	1.85e-05	0.000292	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	1.79e-05	0.000284	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—COX8A—malignant glioma	1.74e-05	0.000275	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PTGS1—malignant glioma	1.73e-05	0.000274	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	1.72e-05	0.000273	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.72e-05	0.000273	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—RAF1—malignant glioma	1.72e-05	0.000273	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—ERBB2—malignant glioma	1.7e-05	0.00027	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	1.67e-05	0.000265	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	1.67e-05	0.000264	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—BCHE—malignant glioma	1.61e-05	0.000255	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—CDKN2B—malignant glioma	1.59e-05	0.000253	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—SLC5A5—malignant glioma	1.59e-05	0.000252	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	1.58e-05	0.00025	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—NCOR1—malignant glioma	1.51e-05	0.00024	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.5e-05	0.000238	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	1.5e-05	0.000238	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.49e-05	0.000236	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	1.48e-05	0.000234	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ASMT—malignant glioma	1.48e-05	0.000234	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	1.48e-05	0.000234	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	1.47e-05	0.000233	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—RAF1—malignant glioma	1.46e-05	0.000232	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MMP9—malignant glioma	1.46e-05	0.000232	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	1.46e-05	0.000231	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	1.42e-05	0.000226	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—BCAN—malignant glioma	1.39e-05	0.00022	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—COX8A—malignant glioma	1.39e-05	0.00022	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—MYC—malignant glioma	1.38e-05	0.000218	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	1.36e-05	0.000215	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PIK3CA—malignant glioma	1.35e-05	0.000213	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PIK3CA—malignant glioma	1.35e-05	0.000213	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	1.32e-05	0.000209	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—VEGFA—malignant glioma	1.31e-05	0.000208	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—STAT3—malignant glioma	1.3e-05	0.000206	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.3e-05	0.000206	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	1.29e-05	0.000204	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—MYC—malignant glioma	1.28e-05	0.000203	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GSTP1—malignant glioma	1.28e-05	0.000203	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—MYC—malignant glioma	1.26e-05	0.0002	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CAT—malignant glioma	1.24e-05	0.000197	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	1.24e-05	0.000197	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	1.24e-05	0.000196	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—MYC—malignant glioma	1.24e-05	0.000196	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—MYC—malignant glioma	1.19e-05	0.000188	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—MYC—malignant glioma	1.19e-05	0.000188	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—EGFR—malignant glioma	1.18e-05	0.000187	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ASMT—malignant glioma	1.18e-05	0.000187	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—NCOR1—malignant glioma	1.18e-05	0.000186	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	1.15e-05	0.000182	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—NOTCH1—malignant glioma	1.15e-05	0.000182	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TNF—malignant glioma	1.12e-05	0.000178	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	1.12e-05	0.000178	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—IDH2—malignant glioma	1.12e-05	0.000177	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—KRAS—malignant glioma	1.12e-05	0.000177	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—BCAN—malignant glioma	1.11e-05	0.000176	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—AKT1—malignant glioma	1.1e-05	0.000174	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—AKT1—malignant glioma	1.1e-05	0.000174	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—PPARG—malignant glioma	1.08e-05	0.000172	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP2B6—malignant glioma	1.05e-05	0.000167	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	1.03e-05	0.000164	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	1.01e-05	0.00016	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—IDH1—malignant glioma	9.62e-06	0.000152	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	9.62e-06	0.000152	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CAV1—malignant glioma	9.58e-06	0.000152	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—AKT1—malignant glioma	9.56e-06	0.000151	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	9.54e-06	0.000151	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SPHK1—malignant glioma	9.31e-06	0.000147	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	9.16e-06	0.000145	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP2C18—malignant glioma	9.12e-06	0.000144	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—IDH2—malignant glioma	8.93e-06	0.000141	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	8.76e-06	0.000139	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—AKT1—malignant glioma	8.74e-06	0.000138	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PIK3CG—malignant glioma	8.73e-06	0.000138	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—AKT1—malignant glioma	8.57e-06	0.000136	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	8.48e-06	0.000134	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PPARG—malignant glioma	8.43e-06	0.000133	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	8.42e-06	0.000133	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP2B6—malignant glioma	8.4e-06	0.000133	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—AKT1—malignant glioma	8.38e-06	0.000133	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—AKT1—malignant glioma	8.22e-06	0.00013	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—AKT1—malignant glioma	8.22e-06	0.00013	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—IDH1—malignant glioma	7.68e-06	0.000122	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PIK3CD—malignant glioma	7.67e-06	0.000122	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SPHK1—malignant glioma	7.43e-06	0.000118	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTT1—malignant glioma	7.38e-06	0.000117	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP2C18—malignant glioma	7.28e-06	0.000115	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	7.16e-06	0.000113	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PTGS1—malignant glioma	6.91e-06	0.000109	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	6.87e-06	0.000109	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PIK3CB—malignant glioma	6.69e-06	0.000106	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PTGS2—malignant glioma	6.63e-06	0.000105	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—BCHE—malignant glioma	6.43e-06	0.000102	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SLC5A5—malignant glioma	6.35e-06	0.000101	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	6.25e-06	9.91e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—MYC—malignant glioma	6.18e-06	9.79e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	6.04e-06	9.56e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTT1—malignant glioma	5.89e-06	9.33e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	5.85e-06	9.26e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PTEN—malignant glioma	5.78e-06	9.16e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PTGS1—malignant glioma	5.52e-06	8.74e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	5.5e-06	8.71e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—BCHE—malignant glioma	5.13e-06	8.13e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTP1—malignant glioma	5.11e-06	8.1e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SLC5A5—malignant glioma	5.07e-06	8.03e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CAT—malignant glioma	4.98e-06	7.88e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.79e-06	7.59e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.75e-06	7.52e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NCOR1—malignant glioma	4.7e-06	7.44e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—AKT1—malignant glioma	4.28e-06	6.79e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.14e-06	6.56e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTP1—malignant glioma	4.08e-06	6.47e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PIK3CA—malignant glioma	4.08e-06	6.46e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CAT—malignant glioma	3.97e-06	6.29e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CAV1—malignant glioma	3.83e-06	6.07e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NCOR1—malignant glioma	3.75e-06	5.94e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PIK3CG—malignant glioma	3.49e-06	5.53e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PPARG—malignant glioma	3.37e-06	5.33e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—AKT1—malignant glioma	3.33e-06	5.28e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PIK3CD—malignant glioma	3.07e-06	4.86e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CAV1—malignant glioma	3.06e-06	4.84e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.92e-06	4.63e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PIK3CG—malignant glioma	2.79e-06	4.41e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PPARG—malignant glioma	2.69e-06	4.26e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PIK3CB—malignant glioma	2.67e-06	4.23e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PTGS2—malignant glioma	2.65e-06	4.2e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PIK3CD—malignant glioma	2.45e-06	3.88e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PTEN—malignant glioma	2.31e-06	3.66e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PIK3CB—malignant glioma	2.13e-06	3.38e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PTGS2—malignant glioma	2.11e-06	3.35e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PTEN—malignant glioma	1.84e-06	2.92e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PIK3CA—malignant glioma	1.63e-06	2.58e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—AKT1—malignant glioma	1.33e-06	2.11e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PIK3CA—malignant glioma	1.3e-06	2.06e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—AKT1—malignant glioma	1.06e-06	1.68e-05	CbGpPWpGaD
